Frontlight ResearchEarly access
Trial site
Bellaire Dermatology Associates
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Psoriasis5 trials
- Atopic dermatitis (eczema)2 trials
- Hidradenitis suppurativa2 trials
- Obesity2 trials
- Vitiligo2 trials
- Chronic spontaneous urticaria1 trial
- Lichen planus1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals5 trials
- Eli Lilly and Company3 trials
- Takeda3 trials
- Amgen1 trial
- Pfizer1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lichen planus1 recruiting
- Obesity1 recruiting
- Psoriasis1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026